Madrazo J L, López J, Puyol P, Pardo J
An Esp Pediatr. 1977 Feb;10(2):123-32.
Alpha1 antitrypsin (A1AT), alpha2 macroglobulin, alpha, quimotrypsin, interalpha1 antitrypsin and trypsin inhibitory capacity in serum of newborn with hyaline membrane disease, are compared with values obtained in other dis orders, and with normal newborn at different gestacional age. Significant decreased level of A1AT and trypsin inhibitory capacity were found in hyaline membrane patients, that were in order to symptoms severity and time in which samples were obtained. A1AT immunofluorescent study of hyaline membrane in died newborns was positive allowing to explain the low levels found in serum. Presence of fibrine IgG, C1a and C3 in hyaline membrane is according to it's composition by plasmatic components. Thus a new pathogenic mecanisme (derived of the plasma viscosity in the alveolar layer) could be present in hyaline membrane formation.
将患有透明膜病的新生儿血清中的α1抗胰蛋白酶(A1AT)、α2巨球蛋白、α-糜蛋白酶、α1抗胰蛋白酶间链和胰蛋白酶抑制能力,与在其他疾病中获得的值以及不同胎龄的正常新生儿的值进行比较。在透明膜病患者中发现A1AT和胰蛋白酶抑制能力水平显著降低,且与症状严重程度和采集样本的时间有关。对死亡新生儿的透明膜进行A1AT免疫荧光研究呈阳性,这有助于解释血清中发现的低水平。透明膜中存在纤维蛋白IgG、C1a和C3,这与其由血浆成分组成相符。因此,在透明膜形成过程中可能存在一种新的致病机制(源自肺泡层中的血浆粘度)。